firmagon
ferring pharmaceuticals a/s - degarelix - prostate neoplasme - terapia endocrină - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.
degarelix accord
accord healthcare s.l.u. - degarelix acetate - prostate neoplasme - other hormone antagonists and related agents - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.
test imunoenzimatic pentru determinarea cantitativa in vitro a testosteronului din probe umane de ser - kit elisa testosterone
sc tody laboratories int. srl -
undecadrol 250 mg/ml soluţie injectabilă
sc balkan pharmaceuticals srl - testosteronum undecanoatum - soluţie injectabilă - 250 mg/ml
lutrate depot 22,5 mg
gp-pharm s.a. - spania - leuprorelinum - pulb+solv. pt. susp. inj. cu elib. prel. - 22,5mg - hormoni si substante inrudite analogi de gonado relina
lutrate depot 22,5 mg
gp-pharm s.a. - spania - leuprorelinum - pulb.+solv. pt. susp. inj. cu elib. prel. - 22,5mg - hormoni si substante inrudite analogi de gonado relina
lutrate depot 3,75 mg
gp pharm, s.a. - spania - leuprorelinum - pulb. + solv. pt. susp. inj. cu elib. prel. - 3,75mg - hormoni si substante inrudite analogi de gonado relina
orgovyx
accord healthcare s.l.u. - relugolix - prostate neoplasme - terapia endocrină - orgovyx is indicated for the treatment of adult patients with advanced hormone-sensitive prostate cancer.
diphereline 11 25 mg 11,25 mg pulbere şi solvent pentru suspensie injectabilă cu eliberare prelungită
ipsen pharma - triptorelinum - pulbere şi solvent pentru suspensie injectabilă cu eliberare prelungită - 11,25 mg
leptoprol 5 mg
sandoz gmbh - austria - leuprorelinum - implant - 5mg - hormoni si substante inrudite analogi de gonado relina